Today, this study presents tangible progress for patients with a devastating genetic brain disease and opens the door for application to other neurological diseases that are treatable
with hematopoietic stem - cell transplantation.
MSC interact
with hematopoietic stem cells (HSC), influencing their homing and differentiation through cell - cell contact and the production of factors and chemokines.
Not exact matches
Researchers at Dana - Farber / Boston Children's Cancer and Blood Disorders Center report promising outcomes from a clinical trial
with patients
with a rare form of bone marrow failure who received a
hematopoietic stem cell transplant (HSCT) after pre-treatment
with immunosuppressive drugs only.
UTSW co-authors include: Co-lead author Maria Winter, a research associate; Dr. Luisella Spiga, a postdoctoral researcher; visiting fellow Lisa Büttner; graduate students Elizabeth Hughes and Caroline Gillis, all of Microbiology; Dr. Breck Duerkop, Instructor, Immunology; Cassie Behrendt, a research technician, Immunology; Dr. Lora Hooper, Professor and Chair of Immunology
with appointments in Microbiology and in the Center for the Genetics of Host Defense, a HHMI Investigator and holder of the Jonathan W. Uhr, M.D. Distinguished Chair in Immunology, and the Nancy Cain and Jeffrey A. Marcus Scholar in Medical Research, in Honor of Dr. Bill S. Vowell; Dr. Luis Sifuentes - Dominguez, Instructor of Pediatrics; Dr. Kayci Huff - Hardy, clinical fellow, Internal Medicine in the Division of Digestive and Liver Diseases; Dr. Andrew Koh, Associate Professor of Pediatrics and Microbiology and in the Harold C. Simmons Comprehensive Cancer Center as well as Director of Pediatric
Hematopoietic Stem Cell Transplantation at Children's Health; and Dr. Ezra Burstein, Professor of Internal Medicine and Molecular Biology and Chief of the Division of Digestive and Liver Diseases.
Last month she filed a request
with the U.S. Food and Drug Administration to offer
hematopoietic stem cells to fetuses
with α thalassemia, a severe form of the disease that is fatal before or soon after birth.
A transplant of
hematopoietic stem cells attempts to cure patients
with certain cancers and other serious illnesses that have not responded to conventional chemotherapies.
She then followed up
with a closer look at role of the Igf2 signaling pathway in coaxing quiescent
hematopoietic stem cells to start dividing and maturing into multi-lineage progenitors that ultimately give rise to specialized blood cells.
One of the most popular models is the immunodeficient nonobese diabetic severe combined immunodeficiency (NOD scid) gamma (NSG) transgenic mouse line, which can be endowed
with a humanized immune system using CD34 +
hematopoietic stem cells.
Researchers at University of California San Diego School of Medicine and Moores Cancer Center have identified RNA - based biomarkers that distinguish between normal, aging
hematopoietic stem cells and leukemia
stem cells associated
with secondary acute myeloid leukemia (sAML), a particularly problematic disease that typically afflicts older patients who have often already experienced a bout
with cancer.
Subsequently, the
hematopoietic system has to be replaced
with stem cells from the blood of a healthy donor.
Hematopoietic stem cell transplantation (HSCT) is a therapeutic option for many patients
with bone marrow failure.
The treatment in the current study, called autologous
hematopoietic stem cell transplantation (AHSCT), was given to patients
with advanced forms of the disease that had failed to respond to other medications.
In contrast, the safety record of
hematopoietic stem cell gene therapy is less clear,
with a significant frequency of gene - therapy induced oncogenesis or clonal outgrowth reported in several
hematopoietic stem cell trials [56], [57].
Along
with the investigational monoclonal antibody, study participants underwent multi-drug chemotherapy, surgery, radiation and autologous
hematopoietic stem cell transplantation.
In addition, transgenic autologous
hematopoietic stem cells can be successfully transplanted in HIV - infected individuals [18] and several phase I adoptive transfer trials of CD4 + T cells treated
with R5 - ZFNs in HIV infected individuals are currently underway.
A Phase 3 Open - Label Randomized Study of Quizartinib (AC220) Monotherapy Versus Salvage Chemotherapy in Subjects
with FLT3 - ITD Positive Acute Myeloid Leukemia (AML) Refractory To or Relapsed After First - line Treatment With or Without Hematopoietic Stem Cell Transplantation (HSCT) Consolida
with FLT3 - ITD Positive Acute Myeloid Leukemia (AML) Refractory To or Relapsed After First - line Treatment
With or Without Hematopoietic Stem Cell Transplantation (HSCT) Consolida
With or Without
Hematopoietic Stem Cell Transplantation (HSCT) Consolidation
• Subject is refractory to or relapsed after first - line AML therapy (
with or without
hematopoietic stem cell transplant (HSCT)-RRB-.
Plerixafor has been approved by the FDA as the first small - molecule CXCR4 antagonist for use in combination
with granulocyte - colony stimulating factor (GCSF) to mobilize
hematopoietic stem cells to the bloodstream for collection and subsequent autologous transplantation in patients
with non-Hodgkin's lymphoma and multiple myeloma.
A detailed comparison of gene expression signatures between ETP ALL tumors and and normal human
hematopoietic progenitor cells revealed a somewhat surprising finding: ETP - ALL expression patterns were less consistent
with early T - cell precursors, as might have been expected, but more similar to the expression profile of normal
hematopoietic stem cells and granulocyte macrophage precursors.
Discussion themes included: -
stem cell heterogeneity -
stem cell fate decisions -
stem cells in regeneration & development -
stem cells in disease & treatment -
stem cell related bioengineering & biomaterial - theoretical
stem cell biology - mathematical modelling
with a focus (but no restriction) on neural
stem cells,
hematopoietic stem cells and diabetes.
Urgent evaluation to help identify optimal
hematopoietic stem cell donor for individuals
with a hematologic disorder and a family history that raises concerns
In that program, we focused on treating children
with both malignant and genetic conditions
with generally allogeneic
hematopoietic stem cell transplantation.
Hematopoietic stem cell mobilization in patients
with multiple myeloma, non-Hodgkin lymphoma or Hodgkin disease
This gave a mixed population of cells
with 20 % expressing CD34, a
hematopoietic stem cell marker,
with some co-expression of endothelial cell markers (CD31, Flk1, and VE - cadherin).
Isolation and characterization of mesenchymal adult bone marrow
stem cells (MSC) and
hematopoietic stem cells (HSC) from healthy donors and patients
with leukemia.
Hematopoietic stem cell transplantation was also more common in patients treated
with inotuzumab ozogamicin (48 % vs 22 %).
Hematopoiesis, where a single
hematopoietic stem cell gives rise to the entire blood system, is an important model for differentiation
with great medical importance.
Plerixafor in combination
with granulocyte - colony stimulating factor (G - CSF) has been approved for
hematopoietic stem cell mobilization to the peripheral blood in patients
with non-Hodgkin's lymphoma and multiple myeloma [54].
Treating HIV: Although
hematopoietic stem cells have been used since World War II to treat victims of radiation, a potential, significant new application was reported just last year: Hematopoietic stem cells were used to successfully treat a patient with HIV, although the procedure is currently risky and much additional research is necessary for it to be widely accep
hematopoietic stem cells have been used since World War II to treat victims of radiation, a potential, significant new application was reported just last year:
Hematopoietic stem cells were used to successfully treat a patient with HIV, although the procedure is currently risky and much additional research is necessary for it to be widely accep
Hematopoietic stem cells were used to successfully treat a patient
with HIV, although the procedure is currently risky and much additional research is necessary for it to be widely accepted and used.
Review of «Evaluating Interaction of Cord Blood
Hematopoietic Stem Progenitor Cells with Functionally Integrated 3D microenvironments» from STEM CELLS Translational Medicine by Stuart P. Atki
Stem Progenitor Cells
with Functionally Integrated 3D microenvironments» from
STEM CELLS Translational Medicine by Stuart P. Atki
STEM CELLS Translational Medicine by Stuart P. Atkinson
Use of a lower dose of rabbit anti — T - lymphocyte globulin (ATLG) was superior to a higher dose in children
with hematologic malignancies undergoing allogeneic
hematopoietic stem cell transplantation (HSCT) from an unrelated donor, according to the results of a study published in Lancet Oncology.
Accelerated aging of immune system after
hematopoietic stem cell transplantation Researchers demonstrated that
hematopoietic stem cell transplantation in patients
with hematological malignancies significantly accelerates aging of immune system.
Generation of an HIV -1-resistant immune system
with CD34 (+)
hematopoietic stem cells transduced
with a triple - combination anti-HIV lentiviral vector.
Hematopoietic stem cells (HSCs) have long been used to provide lifesaving treatments for patients
with malignant and non-malignant hematological disorders.
Patients who receive HSCT receive high doses of chemotherapy,
with or without radiation, followed by infusion of
hematopoietic stem cells (HSCs)-- rare cells that reside within the bone marrow and are capable of producing all varieties of blood cells.
Added to this is the fact that white fat also damages the
hematopoietic stem cells of bone marrow which could results in reduced blood cell formation in bone
with excess fatty infiltration.
By transplanting Wnt - activated
hematopoietic stem and progenitor cells (HSPCs) we demonstrated that Muller cells can be reprogrammed in vivo after fusion
with HSPCs.
Guido Silvestri, MD, division chief of Microbiology and Immunology at the Yerkes Research Center at Emory, and several of his research colleagues performed the first
hematopoietic stem cell transplantation in three rhesus macaques infected
with a simian human immunodeficiency virus (SHIV).
Low - Dose ATLG Prevents GVHD in Pediatric Hematologic Malignancies: A newly published randomized phase III study of pediatric patients showed lower doses of rabbit anti — T - lymphocyte globulin (ATLG) was superior to a higher dose in children
with hematologic malignancies undergoing allogeneic
hematopoietic stem cell transplantation from an unrelated donor.
In her project, Sipkins will investigate molecular characteristics of tissue microenvironments, or «niches,» within the bone marrow and how normal, healthy
hematopoietic stem cells, which give rise to the many kinds of blood cells, compete
with malignant cells to occupy these coveted niches.
The team of researchers harvested
hematopoietic stem cells from three macaques prior to SHIV infection of all six animals in the study, treated the animals
with anti-retroviral therapy (ART) to reduce viral load and mimic the situation in human HIV - infected patients who are treated
with ART, and then exposed the three monkeys from which they had collected
hematopoietic stem cells to a high dose of radiation.
Arndt, C., von Bonin, M., Cartellieri, M., Feldmann, A., Koristka, S., Michalk, I., Stamova, S., Bornhäuser, M., Ehninger, G. and Bachmann, M. Redirection of T cells
with a first fully humanized bispecific CD33 - CD3 antibody efficiently eliminates AML blasts without harming
hematopoietic stem cells.Leukemia, doi: 10.1038 / leu.2013.18.
«I also see
hematopoietic stem cell transplantation, which is a primary concern at City of Hope, becoming a less - toxic treatment
with similar or better long - term effects,» Rosenthal added.
We further describe a mesenchymal sub-population
with stem cell - like characteristics that gives rise to both lineages and, at the same time, acts as a principal component of the
hematopoietic niche by promoting competitive repopulation following lethal irradiation.
One approach in clinical trials is to wipe out the patient's immune system using strong doses of chemotherapy
with antibodies and then use their own previously banked
hematopoietic stem cells (blood forming
stem cells) to regenerate the blood system.
Compared
with the toxicity that we see
with allogeneic donor
hematopoietic stem cell therapy, these toxicities are relatively manageable
with close monitoring and close supportive care.
Myelosuppression is a well - established side effect of current AML therapies,
with prolonged events leading to an increased risk of infections and death.44 Consequently, therapies that preferentially kill leukemic cells over normal bone marrow cells are urgently required, and the overexpression of CD123 on AML leukemic
stem cells and blasts compared
with normal
hematopoietic cells contributes to its attractiveness as a therapeutic target in this disease.6, 45 However, severe myelosuppression and myeloablation have emerged for some investigational CD123 - targeted treatment modalities.
New Insights on Pain and Opioid Use in People
With Sickle Cell Disease After
Hematopoietic Stem Cell Transplant (March 12, 2018)
Furthermore, there is evidence suggesting an association of replication stress on rDNA loci
with the aging of
hematopoietic stem cells, adding more evidence to the general function of the nucleolus in genome integrity and aging.
Not to bore you
with the science, but it seems our bone marrow produces more
hematopoietic stem cells — the ones that lead to white blood cells — during our peak years, though it is important to note that this doesn't protect us from injury or malnutrition, and it doesn't last.